Capio Biosciences to present at the Liquid Biopsy Summit in San Francisco June 17-19th 2019
- Capio Biosciences
- Apr 11, 2019
- 1 min read
Andrew Z. Wang, MD, CEO, Capio Biosciences will present "Capiocyte: A Highly Sensitive Circulating Tumor Cell Capture Assay for Improving Cancer Management"

Comments